Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents Journal:Signal Transduction and Targeted Therapy | 1-Dec-2022 | ||
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity Journal:Frontiers in Immunology | 20-Sep-2022 |